Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Waiting Lists × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 3 Neoplasms 2 Motor Activity 2 Lymphoma, Follicular 2 Breast Neoplasms 2 Anxiety Disorders 2 Stress Disorders, Post-Traumatic 1 Social Stigma 1 Noonan Syndrome 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Legius syndrome 1 Genetic Diseases, Inborn 1 Generalized Anxiety Disorder 1 Fatigue 1 Depression 1 Dementia 1 Costello Syndrome 1 Cognitive Dysfunction 1 Chronic Pain 1 Cardiofaciocutaneous syndrome 1 Breast Cancer With Chronic Lymphedema 1 Breast Cancer Female 1

Interventions

Exercise 6 Transcranial Direct Current Stimulation 4 Neuropsychological Tests 4 Walking 3 Memantine 3 Tablets 2 Standard of Care 2 Patient Reported Outcome Measures 2 Methods 2 Electroencephalography 2 Drug Therapy 2 Donepezil 2 Cognitive Behavioral Therapy 2 mazdutide 1 lithium sulfate 1 lime 1 enzalutamide 1 blueberry extract 1 beta Carotene 1 acetaminophen, aspirin, caffeine drug combination 1 XENP 1595 1 Waiting Lists 1 Vitamin E 1 Vitamin D 1 Ultraviolet Therapy 1 Time 1 Tai Ji 1 Surveys and Questionnaires 1 Sugars 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06584110 2025-06-22

BUDPA

The University of Hong Kong

Phase NA Recruiting

Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡